NCT04688268

Dose for Deep Neuromuscular Blockade Deciding Factor of Neuromuscular Blocker Dose for Deep Neuromuscular Blockade

Find Out the Deciding Factor of Neuromuscular Blocker Dose for Deep Neuromuscular Blockade

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 90 (estimated)
• Sponsor: Seoul National University Bundang Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Find out the deciding factor(total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index, skeletal muscle mass, body fat) of neuromuscular blocker dose for deep neuromuscular blockade.

Detailed description

Before the surgery, total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index were measured by height and weight and skeletal muscle mass and body fat were measured by Bioelectrical impedance analysis (InbodyH20N). Find the highest correlation between the 8 factors (total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index, skeletal muscle mass, body fat) and the amount of rocuronium administered to deep neuromuscular blockade.

Conditions

• Laparoscopic Surgery

Interventions

Type	Name	Description
DRUG	deep neuromuscular blockade	Train of Four=0/4, Post tetanic count 1-2

Timeline

• Start date: 2021-01-10
• Primary completion: 2021-07-30
• Completion: 2021-07-30
• First posted: 2020-12-29
• Last updated: 2020-12-30

Regulatory

• FDA-regulated drug study